Larry Kaiser - 13 Nov 2026 Form 4 Insider Report for Medicus Pharma Ltd. (MDCX)

SEC form
4
Accepted by SEC
17 Nov 2026, 17:12:00 UTC
Prior SEC filing
04 Jun 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Larry Kaiser filed Form 4 for Medicus Pharma Ltd. (MDCX) on 17 Nov 2026.

Key facts

  • This page summarizes Larry Kaiser's Form 4 filing for Medicus Pharma Ltd. (MDCX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Nov 2026, 17:12.

Change

  • Previous filing in this sequence was filed on 04 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048184 Primary reporting owner

Kaiser Larry

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX transaction

Common Shares, no par value

Award

Transaction value
Shares
+14,534
Change %
+181675%
Price
$1.72*
Shares after
14,542
Date
13 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On November 13, 2026, Larry Kaiser entered into a subscription agreement with the Issuer, pursuant to which Mr. Kaiser agreed to purchase 14,534 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .